Motor Neurone Disease (MND / ALS) – Understanding Symptoms, Stages and Ayurvedic Supportive Care
What Is Motor Neurone Disease (MND)?
Motor Neurone Disease (MND) is a group of progressive neurological disorders that affect the motor neurons in the brain and spinal cord. Motor neurons are specialized nerve cells responsible for controlling voluntary muscle movements, including walking, speaking, swallowing and breathing.
In individuals with MND, these nerve cells gradually degenerate and lose their ability to transmit signals to the muscles. As the disease progresses, muscles become increasingly weak and may undergo wasting (atrophy), resulting in difficulties with movement, coordination, speech, swallowing and respiratory function.
Amyotrophic Lateral Sclerosis (ALS) is the most common form of Motor Neurone Disease. Although the condition generally progresses over time, its rate of progression varies considerably among individuals. Some patients experience relatively rapid functional decline, while others may live with the condition for several years or longer.
In advanced stages, respiratory muscle weakness can significantly affect breathing and is a major cause of life-threatening complications. Early diagnosis, regular neurological monitoring and appropriate multidisciplinary supportive care are essential in managing the condition.
Incidence and Prevalence of Motor Neurone Disease
Motor Neurone Disease is a relatively uncommon neurological disorder, with an incidence generally estimated at approximately 2 cases per 100,000 people annually, although rates vary across populations and geographical regions.
The condition is more commonly diagnosed in individuals over 50 years of age, although younger adults can also develop MND. Men are affected slightly more frequently than women.
Approximately 5–10% of ALS cases are familial, meaning they are associated with inherited genetic factors. The majority of cases are sporadic, occurring without a known family history of the disease.
The clinical course, severity and life expectancy vary significantly depending on the type of MND, age at onset, respiratory involvement and other individual factors.
Symptoms and Stages of Motor Neurone Disease
The symptoms of Motor Neurone Disease develop gradually and vary depending on the motor neurons affected. Initially, symptoms may be limited to a particular group of muscles but can progressively involve other parts of the body.
For clinical understanding, the progression of MND is often described in three broad stages:
- Initial Stage: Early muscle weakness, cramps, twitching and difficulties with specific movements or daily activities.
- Advanced Stage: Increasing muscle weakness, reduced mobility, speech and swallowing difficulties, and possible respiratory involvement.
- End Stage: Severe physical impairment, significant swallowing difficulties and advanced respiratory muscle weakness requiring specialized supportive and palliative care.
The progression is not identical in every individual, and these stages should be considered a general description rather than a fixed timeline.
The early symptoms of Motor Neurone Disease (MND) usually develop gradually and may initially be mild or subtle. In many cases, the first signs are limited to specific muscle groups and may go unnoticed or be mistaken for symptoms of other neurological or musculoskeletal conditions.
The pattern of initial symptoms varies depending on which motor neurons are affected first. MND commonly presents as either limb-onset or bulbar-onset disease.
Limb-Onset Motor Neurone Disease
Limb-onset MND is the most common initial presentation, in which symptoms first appear in the arms, hands, legs or feet. Muscle weakness gradually affects everyday activities, coordination and mobility.
Common early symptoms include:
Weakness of Hand Grip: Difficulty holding objects, gripping utensils, fastening buttons, writing or handling small items.
Muscle Fatigue: A persistent feeling of tiredness or reduced strength, particularly when performing routine physical activities.
Muscle Cramps and Pain: Recurrent muscle cramps, stiffness or discomfort, particularly in the arms and legs.
Muscle Twitching: Involuntary muscle movements known as fasciculations, which may be noticed beneath the skin.
Weakness in the Arms or Legs: Difficulty lifting the arms, climbing stairs, walking, standing up or performing previously easy movements.
Loss of Coordination: Increasing clumsiness, frequent stumbling, tripping or difficulty maintaining balance while walking.
Muscle Wasting: Gradual reduction in muscle bulk, particularly in the hands, arms or legs, as the condition progresses.
The symptoms may initially affect only one limb or one side of the body before gradually involving other muscle groups.
Medical note: These symptoms are not exclusive to MND and can occur in several other conditions. Persistent or progressive muscle weakness should be evaluated by a neurologist for an accurate diagnosis.
Bulbar-Onset Motor Neurone Disease
Bulbar-onset Motor Neurone Disease begins by affecting the motor neurons that control the muscles involved in speech, chewing and swallowing. The initial symptoms commonly involve changes in speech and tongue movement, which may gradually become more noticeable.
Common symptoms include:
Slurred Speech (Dysarthria): Speech may become increasingly unclear, slow or difficult to understand due to weakness of the muscles involved in speaking.
Tongue Weakness: Difficulty controlling tongue movements, affecting pronunciation and the ability to move food inside the mouth.
Tongue Wasting and Twitching: The tongue may gradually lose muscle bulk (atrophy) and develop involuntary twitching movements (fasciculations).
Difficulty Swallowing (Dysphagia): As the condition progresses, swallowing food, liquids and even saliva may become increasingly difficult.
Chewing Difficulties: Weakness of the muscles involved in chewing may make eating more challenging.
Changes in Voice: The voice may become weak, nasal or less distinct as the muscles responsible for speech are affected.
As bulbar symptoms progress, patients may experience choking episodes, difficulty maintaining adequate nutrition and an increased risk of aspiration (food or liquid entering the airway). Early assessment by a neurologist and speech and swallowing specialist is important.
Respiratory-Onset Motor Neurone Disease
Respiratory-onset Motor Neurone Disease is a less common presentation in which the muscles responsible for breathing are affected early in the course of the condition. Respiratory muscle weakness can interfere with normal breathing, particularly during sleep or when lying flat.
The initial symptoms may be subtle and are sometimes mistaken for general fatigue or sleep-related problems. Common symptoms include:
Shortness of Breath (Dyspnoea): Difficulty breathing during physical activity and, in some cases, even while resting.
Breathlessness When Lying Flat (Orthopnoea): Difficulty breathing in a lying position, which may improve when sitting upright.
Disturbed Sleep: Frequent waking during the night due to inadequate ventilation and changes in breathing patterns.
Morning Headaches: Headaches upon waking, sometimes associated with increased carbon dioxide levels during sleep.
Excessive Daytime Tiredness: Persistent fatigue, sleepiness and reduced energy due to poor-quality sleep and inadequate overnight ventilation.
Weak Cough: Difficulty coughing effectively to clear mucus and respiratory secretions.
Sleep-Related Breathing Difficulties: Shallow breathing or reduced ventilation during sleep, which may initially go unnoticed.
As respiratory muscle weakness progresses, breathing difficulties may become more pronounced and require specialized respiratory assessment and support.
Important: New or worsening breathlessness, morning headaches, disturbed sleep or difficulty coughing in someone with suspected or diagnosed MND requires prompt medical assessment. Respiratory function should be monitored by an appropriate specialist, as non-invasive ventilation may be necessary.
As Motor Neurone Disease (MND) progresses to an advanced stage, the symptoms generally become more widespread and affect multiple muscle groups and essential bodily functions. The differences between the various forms of MND may become less distinct as the disease increasingly involves the muscles responsible for movement, speech, swallowing and breathing.
The severity and combination of symptoms vary from person to person. Common advanced symptoms include:
- Progressive Muscle Weakness and Wasting: Muscle weakness becomes more pronounced, and the muscles in the arms, legs and other affected areas gradually lose bulk (atrophy). Simple activities such as walking, standing, lifting objects, dressing and maintaining posture may become increasingly difficult. Some individuals eventually require mobility aids or a wheelchair.
- Muscle Spasms, Cramps and Stiffness: Muscle twitching (fasciculations), cramps and involuntary spasms may become more noticeable. Increased muscle tone and stiffness (spasticity) can affect movement, coordination and flexibility, sometimes causing considerable discomfort.
- Muscle and Joint Pain: Persistent muscle stiffness, spasms, reduced mobility and changes in posture may contribute to muscle and joint pain. Limited movement can also increase the risk of joint stiffness and pressure-related discomfort.
- Difficulty Swallowing (Dysphagia): Weakness of the muscles involved in swallowing can make it increasingly difficult to consume solid foods, liquids and saliva. This may lead to choking, dehydration, nutritional deficiencies and an increased risk of aspiration pneumonia.
- Difficulty Speaking and Communicating: Weakness of the tongue, throat and facial muscles can significantly affect speech clarity and voice control. Speech may become increasingly slurred or difficult to understand. Some individuals may eventually require alternative communication devices or assistive technology.
- Excessive Salivation and Drooling: Weakness of the muscles responsible for controlling saliva and swallowing can result in saliva accumulating in the mouth and involuntary drooling. Some individuals may also experience thick, sticky saliva, making oral care and swallowing more difficult.
- Uncontrollable Yawning: Some people with MND experience episodes of excessive or involuntary yawning, even when they are not tired. These episodes may occur alongside other involuntary emotional expressions and can sometimes cause jaw discomfort.
- Emotional Changes: MND may affect the neural pathways involved in emotional expression. Some individuals experience involuntary episodes of crying or laughter that are disproportionate to their actual feelings or the surrounding situation. This condition is known as pseudobulbar affect or emotional lability.
- Changes in Cognitive Function: Although many individuals with MND retain their memory, intelligence and decision-making abilities, some may experience difficulties with concentration, planning, memory, language and behavioural changes. A proportion of patients may also develop frontotemporal dementia (FTD), which can affect personality, judgement and social behaviour.
- Progressive Breathing Difficulties: Weakness of the respiratory muscles gradually reduces the ability to breathe effectively and clear respiratory secretions. Initially, breathlessness may occur during physical activities, but as the condition advances, it can also develop at rest or while lying down. Disturbed sleep, morning headaches, daytime fatigue and a weak cough may indicate respiratory muscle involvement. In advanced cases, non-invasive ventilation or other respiratory support may be required.
As MND advances, patients may require increasing assistance with daily activities, nutrition, communication, mobility and breathing. Multidisciplinary medical care, respiratory monitoring, nutritional support, physiotherapy, occupational therapy and palliative care play an important role in maintaining comfort, dignity and quality of life.
Medical note: The progression and severity of advanced MND symptoms vary considerably. New swallowing difficulties, choking episodes, worsening breathlessness or an ineffective cough require prompt medical assessment.
Living with Motor Neurone Disease (MND) can bring significant physical, emotional and psychological challenges. In addition to symptoms directly associated with nerve and muscle involvement, some people may experience secondary symptoms related to the stress, uncertainty and lifestyle changes associated with the condition.
These symptoms can affect emotional well-being, sleep, daily activities and overall quality of life. They may vary from person to person and can occur at different stages of the disease.
Common secondary symptoms include:
Depression: Persistent sadness, loss of interest, low mood or feelings of hopelessness. Coming to terms with an MND diagnosis and adapting to progressive changes can contribute to emotional distress.
Anxiety: Excessive worry, fear or restlessness, sometimes related to changes in physical abilities, communication, swallowing, breathing or concerns about the future.
Insomnia and Sleep Disturbances: Difficulty falling asleep, frequent waking or poor-quality sleep. Discomfort, muscle cramps, anxiety, breathing difficulties or changes in daily routines may contribute to sleep problems.
In the advanced or final stages of Motor Neurone Disease (MND), muscle weakness may become severe and affect most voluntary movements. The extent and rate of progression vary between individuals, but some people may experience profound physical dependence and increasing difficulty with essential bodily functions.
Common features during the end stage may include:
Severe Muscle Weakness and Paralysis: Muscle weakness may progress to the point where a person has very limited or no voluntary movement in their arms, legs and trunk. They may become completely dependent on caregivers for mobility, personal care and daily activities.
Significant Breathing Difficulties: Progressive weakness of the respiratory muscles can make breathing increasingly difficult. Some individuals may experience breathlessness, a weak cough, difficulty clearing airway secretions and reduced ability to breathe effectively, particularly during sleep. Non-invasive ventilation or other respiratory support may be considered according to the individual's needs and preferences.
Clinical note: Complete paralysis does not occur in every person with MND, and the final stage cannot be defined by a fixed set of symptoms or timeline. Severe or worsening breathing difficulty requires prompt assessment by the treating medical team.
CLASSIFICATION
There are different types of MND, each affecting people in different ways.
Amyotrophic lateral sclerosis (ALS) is the most common form of the motor neuron diseases. The disorder is characterized by rapidly progressive weakness, muscle atrophy and fasciculations, muscle spasticity, difficulty speaking (dysarthria), difficulty swallowing (dysphagia), and decline in breathing ability. The disorder causes muscle weakness and atrophy throughout the body caused by degeneration of the upper and lower motor neurons. Unable to function, the muscles weaken and atrophy.
Affected individuals may ultimately lose the ability to initiate and control all voluntary movement, although bladder and bowel sphincters and the muscles responsible for eye movement are usually, but not always, spared. Sensory nerves and the autonomic nervous system are generally unaffected meaning the majority of people with ALS will maintain sight, hearing, touch, smell, and taste. Bladder and bowel functions are also rarely affected by ALS.
The earliest symptoms of ALS are typically obvious weakness and/or muscle atrophy. Other presenting symptoms include muscle fasciculation (twitching), cramping, or stiffness of affected muscles; muscle weakness affecting an arm or a leg; and/or slurred and nasal speech. The parts of the body affected by early symptoms of ALS depend on which motor neurons in the body are damaged first.
About 75% of people contracting the disease experience “limb onset” ALS, i.e., first symptoms in the arms or legs. Patients with the leg onset form may experience awkwardness when walking or running or notice that they are tripping or stumbling, often with a “dropped foot” which drags gently along the ground. Arm-onset patients may experience difficulty with tasks requiring manual dexterity such as buttoning a shirt, writing, or turning a key in a lock.
Occasionally, the symptoms remain confined to one limb for a long period of time or for the whole length of the illness; this is known as monomelic amyotrophy.
About 25% of cases are “bulbar onset” ALS. These patients first notice difficulty speaking clearly or swallowing. Speech may become slurred, nasal in character, or quieter. Other symptoms include difficulty swallowing and loss of tongue mobility.
A smaller proportion of patients experience “respiratory onset” ALS, where the intercostal muscles that support breathing are affected first. A small proportion of patients may also present with what appears to be frontotemporal dementia, but later progresses to include more typical ALS symptoms.
Over time, patients experience increasing difficulty moving, swallowing (dysphagia), and speaking or forming words (dysarthria). Symptoms of upper motor neuron involvement include tight and stiff muscles (spasticity) and exaggerated reflexes (hyperreflexia) including an overactive gag reflex. An abnormal reflex commonly called Babinski’s sign also indicates upper motor neuron damage. Symptoms of lower motor neuron degeneration include muscle weakness and atrophy, muscle cramps, and fleeting twitches of muscles that can be seen under the skin (fasciculations). Around 15–45% of patients experience pseudobulbar affect, also known as “emotional lability”, which consists of uncontrollable laughter, crying or smiling, attributable to degeneration of bulbar upper motor neurons resulting in exaggeration of motor expressions of emotion. To be diagnosed with ALS, patients must have signs and symptoms of both upper and lower motor neuron damage that cannot be attributed to other causes.
Although the order and rate of symptoms varies from person to person, eventually most patients are not able to walk, get out of bed on their own, or use their hands and arms. Regardless of the part of the body first affected by the disease, muscle weakness and atrophy spread to other parts of the body as the disease progresses. In limb-onset ALS, symptoms usually spread from the affected limb to the opposite limb before affecting a new body region, whereas in bulbar-onset ALS symptoms typically spread to the arms before the legs.
Disease progression tends to be slower in patients who are younger than 40 at onset, have disease restricted primarily to one limb, and those with primarily upper motor neuron symptoms. Conversely, progression is faster and prognosis poorer in patients with bulbar-onset disease, respiratory-onset disease, and frontotemporal dementia.
Difficulty swallowing and chewing making eating normally very difficult and increase the risk of choking or aspirating food into the lungs. In later stages of the disease, aspiration pneumonia and maintaining a healthy weight can become a significant problem and may require insertion of a feeding tube. As the diaphragm and intercostal muscles (rib cage) that support breathing weaken, measures of lung function such as forced vital capacity and inspiratory pressure diminish. In respiratory onset ALS, this may occur before significant limb weakness is apparent. External machines such as bilevel positive pressure ventilation (BiPAP) are frequently used to support breathing, first at night, and later during the daytime as well. BiPAP is only a temporary remedy, however, and it is recommended that long before BiPAP stops being effective, patients should decide whether to have a tracheotomy and long term mechanical ventilation. Most people with ALS die of respiratory failure or pneumonia.
Although respiratory support can ease problems with breathing and prolong survival, it does not affect the progression of ALS. Most people with ALS die from respiratory failure, usually within three to five years from the onset of symptoms. The median survival time from onset to death is around 39 months, and only 4% survive longer than 10 years.
PBP is a disease that attacks the nerves supplying the bulbar muscles. These disorders are characterized by the degeneration of motor neurons in the cerebral cortex, spinal cord, brain stem, and pyramidal tracts. This specifically involves the glossopharyngeal nerve (IX), vagus nerve (X), and hypoglossal nerve (XII).
Prognosis for PBP patients is poor. Progressive bulbar palsy symptoms can include progressive difficulty with chewing, talking, and swallowing. Patients can also exhibit reduced gag reflexes, weak palatal movements, fasciculations, and weak movement of the facial muscles and tongue. In advanced cases of PBP, the patient may be unable to protrude their tongue or manipulate food in their mouth.
Patients with early cases of PBP have difficulty with pronunciations, particularly lateral consonants (linguals) and velars, and may show problems with drooling saliva. If the corticobulbar tract is affected a pseudobulbar affect with emotional changes may occur.
Because PBP patients have such difficulty swallowing, food and saliva can be inhaled into the lungs. This can cause gagging and choking, and it increases the risk of pneumonia. Death, which is often from pneumonia, usually occurs 1 to 3 years after the start of the disorder.
Is a rare subtype of motor neuron disease (MND) which affects only the lower motor neurones. PMA is thought to account for around 4% of all MND cases. This is in contrast to amyotrophic lateral sclerosis (ALS), the most common form of MND, which affects both the upper and lower motor neurones, or primary lateral sclerosis, another rare MND variant, which affects only the upper motor neurons. The distinction is important because PMA is associated with a better prognosis than other forms of MND.
As a result of lower motor neurone degeneration, the symptoms of PMA include:
- atrophy
- fasciculations
- muscle weakness
Some patients have symptoms restricted only to the arms or legs (or in some cases just one of either). These cases are referred to as “Flail Arm” (FA) or “Flail Leg” (FL) and are associated with a better prognosis.
Pseudobulbar palsy results from an upper motor neuron lesion to the corticobulbar pathways in the pyramidal tract. Patients have difficulty chewing, swallowing (Dysphagia) and demonstrate slurred speech (Dysarthria) (often initial presentation). Individuals with pseudobulbar palsy also demonstrate inappropriate emotional outbursts.
DIAGNOSTIC CRITERIA
This is of course a diagnosis which needs a great deal of careful consideration given the poor prognosis. Nevertheless, it is equally important to ensure that the diagnosis is not unduly delayed. One study found that the average time from suspected diagnosis to confirmation was one year.
Diagnosis should be made after consideration of the clinical signs and symptoms together with investigations to exclude other causes.
Because of the very variable clinical presentation, the diagnostic criteria below have been devised, taking into account investigations to confirm the diagnosis and refute other possible causes (revised El Escorial Criteria):
Presence of:
- Evidence of LMN degeneration by clinical, electrophysiological or neuropathological examination.
- Evidence of UMN degeneration by clinical examination.
- Progressive spread of symptoms or signs within a region or to other regions, as determined by history or examination
Together with the absence of:
- Electrophysiological and pathological evidence of other disease processes that might explain the signs of LMN and/or UMN degeneration.
- Neuroimaging evidence of other disease processes that might explain the observed clinical and electrophysiological signs.
There is currently no single laboratory test or investigation that can independently confirm a diagnosis of Motor Neurone Disease (MND). Diagnosis is primarily based on a detailed neurological assessment, the pattern of symptoms, clinical examination and investigations that help identify characteristic features of the disease and exclude other conditions with similar symptoms.
The diagnostic process is usually conducted under the supervision of an experienced neurologist. In some individuals, repeated clinical assessments and investigations over several months may be necessary before the diagnosis becomes clear. This careful approach is important because conditions such as spinal disorders, nerve diseases and certain muscle disorders can produce symptoms resembling MND.
The following investigations may be recommended during the diagnostic evaluation:
Electromyography (EMG) and Nerve Conduction Studies (NCS)
Electromyography (EMG) and Nerve Conduction Studies (NCS) are important investigations in the evaluation of MND. They help assess the electrical activity of muscles and the functioning of peripheral nerves.
Electromyography (EMG): This test evaluates the electrical activity of muscles using a fine needle electrode inserted into selected muscles. In MND, EMG may demonstrate evidence of active denervation, such as fibrillation potentials and fasciculation potentials, together with chronic neurogenic changes associated with reinnervation. Motor unit potentials may show increased amplitude and duration, often with altered morphology.
Nerve Conduction Studies (NCS): This test measures how electrical signals travel along peripheral nerves. In typical MND, sensory nerve conduction is generally preserved, although motor nerve responses may show abnormalities as motor neurons and their axons are affected.
EMG and NCS findings must always be interpreted alongside the patient's symptoms and neurological examination. The pattern and distribution of abnormalities across different muscles help distinguish MND from conditions affecting individual nerves, nerve roots or muscle tissue.
CT Scan and MRI of the Brain and Spinal Cord
Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) scans may be performed to identify or exclude structural abnormalities that can produce symptoms similar to MND.
MRI is particularly useful for examining the brain, spinal cord and cervical spine. It can help identify conditions such as spinal cord compression, cervical spondylosis, tumours, inflammatory disorders and other neurological abnormalities.
These imaging investigations do not independently confirm MND. Their primary role in the diagnostic process is to exclude alternative explanations for the patient's symptoms.
Blood Tests and Other Laboratory Investigations
Blood tests may be recommended to identify medical conditions that can mimic some of the symptoms of MND. These investigations help exclude nutritional deficiencies, infections, metabolic disorders, autoimmune conditions and other potentially treatable causes of muscle weakness.
Depending on the patient's clinical presentation, investigations may include:
Vitamin B12 and Folate Levels: To identify nutritional deficiencies that may affect nerve function.
Creatine Kinase (CK): To assess possible muscle damage or muscle disorders.
Thyroid Function Tests: To identify thyroid disorders that may contribute to muscle weakness.
HIV and Other Infection Screening: Selected tests may be advised when clinically indicated.
Serum Protein Electrophoresis: To investigate certain blood protein abnormalities associated with neurological conditions.
Anti-GM1 Antibodies: May be considered when multifocal motor neuropathy is suspected.
Additional Specialized Tests: Other investigations may be recommended to exclude uncommon neurological, metabolic, genetic or autoimmune conditions.
The selection of blood tests depends on the individual's symptoms, medical history and neurological findings. Not every patient requires all these investigations.
Muscle Biopsy
Muscle biopsy involves collecting a small sample of muscle tissue for examination under a microscope. It is not a routine investigation for diagnosing typical MND.
It may be considered when the clinical findings suggest a muscle disorder or another condition that can resemble MND. Examination of the muscle tissue can help identify certain inflammatory, metabolic or structural muscle abnormalities.
Genetic Testing
Genetic testing may be recommended in selected patients, particularly when there is a family history of MND or when inherited forms of the disease are suspected. It can help identify genetic changes associated with familial MND and may provide information relevant to genetic counselling and treatment options in eligible cases.
Why Is a Detailed Diagnostic Evaluation Important?
Several neurological and muscular conditions can present with symptoms similar to MND, including cervical spinal cord compression, multifocal motor neuropathy, peripheral neuropathies and certain muscle diseases.
A thorough diagnostic evaluation helps the neurologist distinguish MND from these conditions and identify potentially treatable alternatives. The diagnosis is therefore based on the overall clinical picture rather than the result of any single investigation.
If you or a family member experiences progressive muscle weakness, muscle wasting, unexplained twitching, difficulty speaking or swallowing, or other concerning neurological symptoms, consultation with a neurologist is important for timely assessment and appropriate management.
Although there is currently no definitive cure for Motor Neurone Disease (MND), several medical treatments and supportive interventions are available to help manage symptoms, address complications and improve quality of life. Treatment is generally individualized according to the type of MND, symptoms, rate of progression and overall health of the patient.
Riluzole – A Disease-Modifying Medication
Riluzole is one of the established medications used in the treatment of Amyotrophic Lateral Sclerosis (ALS), the most common form of MND. It acts primarily by reducing the release of glutamate, an excitatory neurotransmitter involved in communication between nerve cells.
Excessive glutamate activity is thought to contribute to motor neuron damage in ALS. By modifying this process, Riluzole may help modestly prolong survival, although it does not reverse existing motor neuron damage or restore lost muscle function.
Clinical studies have demonstrated a modest survival benefit, generally measured in months, with some evidence of a benefit in tracheostomy-free survival. Treatment is usually considered early after diagnosis, following assessment by a neurologist.
Riluzole is generally tolerated by many patients, but it can cause side effects, including nausea, fatigue and changes in liver function. Regular liver-function monitoring is important during treatment, and patients should follow their neurologist's advice regarding dosage and follow-up.
Medications for Managing MND Symptoms
In addition to disease-modifying medication, various medicines may be prescribed to manage symptoms and complications associated with MND. The choice of medication depends on the individual's symptoms, medical history and response to treatment.
Common examples include:
Excessive Salivation and Drooling: Anticholinergic medicines, such as hyoscine, may help reduce excessive saliva production. Other treatments may be considered when drooling persists.
Muscle Cramps and Spasticity: Medicines such as baclofen and tizanidine may be prescribed to reduce muscle stiffness and spasms. Other medications may be considered in selected cases, depending on the nature and severity of symptoms.
Breathlessness and Respiratory Distress: Respiratory assessment and appropriate ventilatory support are important. In advanced disease or palliative care, carefully prescribed opioid medicines may help relieve severe breathlessness. Their use requires medical supervision because they can suppress respiratory function.
Depression and Anxiety: Psychological support, counselling and antidepressant medication may help manage depression and significant emotional distress associated with MND.
Pain Management: Pain can occur due to muscle cramps, stiffness, reduced mobility, joint problems and prolonged positioning. Mild to moderate pain may sometimes be managed with appropriate analgesics, while more severe pain may require stronger prescription medicines, including opioids. Treatment should be individualized.
Nutritional Support and Management of Swallowing Difficulties
As MND progresses, weakness of the muscles involved in chewing and swallowing can lead to dysphagia. Patients may experience difficulty swallowing food, liquids or saliva, increasing the risk of choking, aspiration, dehydration and malnutrition.
Nutritional assessment and swallowing evaluation by appropriate specialists are important components of MND care. Depending on the patient's condition, dietary modifications, altered food consistency and guidance from a speech and language therapist or dietitian may help maintain safe and adequate nutrition.
When swallowing becomes significantly impaired or oral intake is insufficient, a feeding tube may be considered.
One commonly used option is Percutaneous Endoscopic Gastrostomy (PEG). This procedure involves placing a feeding tube directly into the stomach through the abdominal wall, using endoscopic guidance. It allows nutritional fluids, prescribed feeds and certain medications to be administered when swallowing is no longer safe or adequate.
The timing of PEG placement should be discussed with the neurological and nutrition teams. It is generally preferable to consider this option before severe nutritional decline or advanced respiratory impairment develops. The procedure, potential benefits and risks should be discussed with the patient and family as part of an individualized care plan.
Multidisciplinary Support in MND
Medical management of MND extends beyond medication. A multidisciplinary team may include neurologists, respiratory specialists, physiotherapists, occupational therapists, speech and language therapists, dietitians, psychologists and palliative care professionals.
Regular assessment of respiratory function, swallowing, nutrition, mobility, communication and emotional well-being helps identify complications and guide appropriate supportive interventions throughout the course of the disease.
Ayurveda Perspective and Management of Motor Neurone Disease (MND/ALS)
In Ayurveda, health (Swasthya) is understood as a harmonious balance between the physical body, senses and mind. When these function in their natural state and maintain their physiological balance, a person is considered to be in a state of well-being. This holistic understanding forms the foundation of the Ayurvedic approach to health and disease.
The Role of Vata in Motor Neurone Disease (MND/ALS)
Although Motor Neurone Disease (MND), including Amyotrophic Lateral Sclerosis (ALS), does not have an exact equivalent in classical Ayurvedic literature, its clinical features may be understood within the traditional framework of Vata-predominant disorders (Vata Vyadhi).
Vata is one of the three fundamental Doshas in Ayurveda, along with Pitta and Kapha. It is traditionally regarded as the principal factor responsible for movement, communication and several essential physiological activities of the body.
According to Ayurvedic principles, Vata is associated with:
- Nervous system functions: Sensory perception, coordination, communication and the regulation of voluntary and involuntary movements.
- Respiratory functions: The processes involved in breathing and the movement of vital air.
- Circulation and elimination: The movement of blood and other bodily substances, as well as excretory functions.
- Physical and mental activities: Movement of the limbs, speech, sensory activities and cognitive functions.
These traditional descriptions share certain functional similarities with activities attributed to the central, peripheral and autonomic nervous systems in modern medicine. However, Vata is an Ayurvedic concept and is not scientifically identical to the nervous system.
Several symptoms of MND, including muscle fasciculations (twitching), cramps, muscle wasting, progressive weakness, spasticity and bulbar symptoms affecting speech and swallowing, may be interpreted within the classical Ayurvedic understanding of Vata derangement.
Ayurveda's Line of Treatment: Pacifying Vata and Restoring Balance
Ayurvedic classics describe a wide range of Vata-related disorders involving different tissues, organs and physiological functions. These conditions are traditionally understood to include degenerative, obstructive, inflammatory and functional manifestations.
The Ayurvedic approach primarily focuses on Vata Shamana (pacification of Vata) and maintaining the functional equilibrium of all three Doshas — Vata, Pitta and Kapha.
Treatment is individualized according to the patient's constitution (Prakriti), symptoms, disease stage, physical strength and overall health condition.
CHARAKA – The Speciality Ayurveda: Our Commitment to MND/ALS Care
CHARAKA – THE SPECIALITY AYURVEDA, Institute of Panchakarma & Research, has been providing Ayurvedic consultations and care for individuals with Motor Neurone Disease (MND/ALS) since 2003.
Over the years, our clinical experience and understanding of this complex neurological condition have continued to evolve. We remain committed to providing individualized Ayurvedic care, patient education and guidance to individuals living with MND and their families.
Our approach is based on classical Ayurvedic principles and typically considers four broad components of management.
Four Principles of Ayurvedic Management
1. Samshodhana – Purificatory Therapies
Samshodhana refers to classical cleansing procedures, including selected Panchakarma therapies. These procedures are traditionally intended to address Dosha imbalances. Their suitability must be carefully assessed in MND patients, particularly those with significant weakness, respiratory difficulties, swallowing problems or reduced physical strength.
2. Samshamana – Palliative and Symptom-Oriented Care
Samshamana involves individualized Ayurvedic medicines and supportive measures intended to help manage selected symptoms and promote general well-being. Internal medicines should be prescribed only after reviewing the patient's medical history, current medications and relevant organ-function assessments.
3. Kayakalpa – Rejuvenation and Supportive Care
Kayakalpa represents traditional Ayurvedic rejuvenation principles aimed at supporting general health, strength and well-being. Appropriate restorative therapies, dietary measures and supportive interventions may be considered according to the individual's condition.
4. Sattvavajaya – Psychological and Emotional Support
Sattvavajaya refers to traditional Ayurvedic approaches to supporting mental and emotional well-being. Counselling, reassurance, relaxation practices and guidance for patients and caregivers may help address anxiety, emotional distress and the psychological challenges associated with living with MND.
Along with these approaches, appropriate dietary and lifestyle modifications are recommended according to the patient's nutritional requirements, swallowing ability, digestive capacity, mobility and general health.
Role of Panchakarma in the Ayurvedic Management of MND/ALS
Panchakarma (Ayurvedic bio-cleansing and detoxification therapy) forms the cornerstone of our therapeutic protocol for MND at CHARAKA. Because MND involves deep-seated Vata aggravation and cellular-level blockages, simple oral medication alone is insufficient.
Panchakarma plays a pivotal role in the following ways:
-
Eliminating Metabolic Toxins (Ama): Specific Panchakarma therapies help clear cellular debris and inflammatory toxins from channels (Srotas), allowing better nutrient absorption and metabolic flow to nerve tissues.
-
Pacifying Vata at the Root: Specialized external and internal bio-purificatory measures (such as Basti or medicated enemas, considered the premier treatment for Vata disorders) help calm the hyperactive Vata biofactor directly.
-
Nourishing Depleted Tissues (Brimhana): Nourishing Panchakarma procedures—such as Navarakizhi (Shashtika Sali Pinda Sweda / rice-pouch massage) and Abhyanga (medicated oil therapies)—provide deep nourishment to wasted muscles and declining motor neurons.
-
Enhancing Quality of Life: Regular Panchakarma sessions help relieve muscle stiffness, manage painful cramps,preserve joint flexibility, and support better motor functioning.
The selection, intensity and duration of these procedures require careful clinical assessment. Patients with advanced muscle weakness, respiratory impairment, swallowing difficulties, poor nutritional status or significant physical dependence may not tolerate intensive Panchakarma procedures. In such cases, gentle supportive measures or avoiding certain procedures may be more appropriate.
Can Ayurvedic Treatment Be Combined with Riluzole?
Riluzole is a medication prescribed by neurologists for certain individuals with ALS. Patients should continue their prescribed neurological treatment and should never discontinue or modify Riluzole without consulting their treating neurologist.
Ayurvedic medicines should not automatically be assumed to be free from interactions with Riluzole or other prescribed medications.
Patients should inform both their neurologist and Ayurvedic physician about all medicines, herbal preparations and supplements they are taking. Any proposed Ayurvedic supportive care should be considered in coordination with ongoing neurological treatment and medical monitoring.
Patient Education and Support at CHARAKA
Apart from providing consultations and individualized Ayurvedic care, CHARAKA places importance on educating MND patients and their relatives about the condition, its symptoms, available supportive approaches and the importance of continued medical supervision.
We believe that patients and caregivers should have access to clear information and appropriate guidance to help them understand the challenges associated with MND and make informed decisions about their care.
Our aim is to provide compassionate, individualized support while respecting the medical needs, preferences and dignity of every patient.
Understanding the Limitations of Treatment and the Importance of Early Diagnosis
Despite advances in medical care and the availability of various supportive approaches, a complete cure for Motor Neurone Disease is not currently available. Ayurvedic classics describe certain difficult-to-treat conditions under the category of Kashta Saadhya Roga, meaning conditions that are difficult to manage or cure. This is a traditional classification and should not be interpreted as evidence that Ayurvedic treatment can cure or reverse MND.
Early diagnosis and appropriate medical intervention are important in MND. Prompt neurological assessment helps establish the diagnosis, identify complications and plan appropriate care. Supportive management can address symptoms, nutritional needs, respiratory function, mobility and emotional well-being.
The suitability and potential benefits of Ayurvedic supportive interventions vary between individuals and depend on the disease stage, general health and associated complications.
CRITICAL FACTOR TO UNDERSTAND: EARLY-DIAGNOSED AND EARLY-TREATED CASES RESPOND THE MOST FAVORABLY TO PANCHAKARMA AND AYURVEDIC THERAPIES. THE OVERALL TREATMENT SUCCESS AND FUNCTIONAL PRESERVATION DECREASE SIGNIFICANTLY AS THE DISEASE BECOMES CHRONIC.
At CHARAKA, we are committed to providing individualized Ayurvedic supportive care, patient education and guidance, while encouraging continued neurological supervision and comprehensive medical management.
A Holistic Path Forward for Motor Neurone Disease (MND/ALS)
Motor Neurone Disease requires long-term, multidisciplinary care and continuous support. As the condition can affect mobility, speech, swallowing, breathing and emotional well-being, comprehensive management should address not only neurological symptoms but also the patient's overall comfort, nutritional needs, functional abilities and quality of life.
Ayurveda offers a traditional holistic approach based on individualized assessment, Vata Shamana, selected Panchakarma procedures, supportive medicines, dietary guidance and lifestyle modifications. At CHARAKA, these approaches are considered with careful attention to the patient's disease stage, physical strength and overall medical condition.
While Ayurvedic care may be explored as a supportive component of an integrated care plan, it should not replace neurological treatment, prescribed medicines, respiratory support or other essential medical interventions. Our emphasis is on providing responsible, personalized care while helping patients and their families understand and manage the challenges associated with MND.
Schedule a Clinical Consultation at CHARAKA
Begin your consultation journey with CHARAKA – The Speciality Ayurveda, Institute of Panchakarma & Research, Hyderabad.
Each consultation involves an assessment of the patient's medical history, neurological condition, symptoms, disease stage, current medications and overall health status. Based on this evaluation, an individualized Ayurvedic supportive care plan may be considered in coordination with ongoing neurological management.
Contact CHARAKA
📞 Phone: +91 7660000133 | 040 66666636 | 040 66329888
📧 Email: info@charaka.org
📍 Location: Banjara Hills, Hyderabad
Consultations are available by prior appointment only, ensuring dedicated clinical attention, continuity of care and privacy for patients and their families.
What is Motor Neurone Disease (MND)?
Motor Neurone Disease (MND) is a progressive neurological condition that affects the motor neurons responsible for controlling voluntary muscle movements. As these nerve cells gradually degenerate, patients may develop muscle weakness, wasting, twitching, stiffness and difficulties with walking, speaking, swallowing and breathing. Amyotrophic Lateral Sclerosis (ALS) is the most common form of MND.
What are the early symptoms of Motor Neurone Disease?
Early symptoms of MND may include weakness in the arms or legs, difficulty gripping objects, frequent muscle cramps, twitching (fasciculations), muscle wasting and unexplained tripping or stumbling. Some individuals initially experience slurred speech, difficulty swallowing or breathing-related symptoms. The pattern and progression of symptoms vary from person to person.
What is the difference between MND and ALS?
Motor Neurone Disease (MND) is an umbrella term for a group of neurological disorders affecting motor neurons. Amyotrophic Lateral Sclerosis (ALS) is the most common type of MND and involves degeneration of both upper and lower motor neurons. Other forms include Progressive Bulbar Palsy (PBP), Progressive Muscular Atrophy (PMA) and Primary Lateral Sclerosis (PLS).
What causes Motor Neurone Disease?
The exact cause of MND is not fully understood. Most cases occur sporadically without a known family history, while a smaller proportion are associated with inherited genetic changes. Several genetic and environmental factors are being investigated, but no single cause explains all cases.
How is Motor Neurone Disease diagnosed?
MND is diagnosed through a detailed neurological examination, clinical history and investigations to identify motor neuron involvement and exclude other conditions. Tests may include Electromyography (EMG), Nerve Conduction Studies (NCS), MRI scans and relevant blood investigations. Diagnosis and monitoring should be undertaken by an experienced neurologist.
Can Motor Neurone Disease be treated with Ayurveda?
In Ayurveda, the symptoms of MND are understood primarily through the concept of Vata imbalance, as many clinical features, such as muscle wasting, weakness, cramps, twitching and stiffness, resemble classical descriptions of Vata-related disorders. Ayurvedic care may be considered as complementary supportive care, focusing on individualized assessment and general well-being. However, there is currently insufficient high-quality clinical evidence to establish Ayurveda as a cure or as a proven method of slowing MND progression.
How is MND understood in Ayurveda?
Although MND does not have a precise equivalent in classical Ayurvedic texts, its clinical manifestations may be interpreted within the broader framework of Vata Vyadhi (Vata-related disorders). Vata governs movement and neuromuscular functions according to Ayurvedic principles. The Ayurvedic approach traditionally emphasizes Vata Shamana (pacification of aggravated Vata), consideration of the balance of the three Doshas and individualized management based on the patient's condition.
What is the Ayurvedic treatment approach for MND at CHARAKA?
At CHARAKA – The Speciality Ayurveda, the Ayurvedic approach is based on classical principles and individualized assessment. The treatment framework may consider four broad components: Shodhana (purificatory procedures, when appropriate), Shamana (palliative management), Kayakalpa (rejuvenation-oriented therapies) and Sattvavajaya (psychological support and counselling). Treatment suitability depends on disease severity, physical capacity, swallowing and respiratory function, and ongoing neurological care. These approaches should be understood as complementary supportive care rather than established disease-modifying treatment.
What is the role of Panchakarma in Motor Neurone Disease?
Panchakarma is an important component of Ayurvedic therapeutics and may be considered in selected patients following careful clinical assessment. The choice of procedures depends on muscle strength, mobility, nutritional status, respiratory function and the overall condition of the patient. Intensive purification procedures may not be suitable for individuals with advanced MND, swallowing difficulties or respiratory compromise. Panchakarma should never delay or replace essential neurological and supportive care.
Can Ayurvedic treatment cure Motor Neurone Disease?
At present, there is no established cure for Motor Neurone Disease through Ayurveda or conventional medicine. Ayurvedic interventions may be explored as complementary supportive care, but claims of complete recovery, reversal of motor neuron damage or guaranteed improvement cannot be scientifically established. The focus should remain on appropriate medical management, symptom relief, maintaining function and improving quality of life.
Can Ayurvedic treatment be taken along with Riluzole?
Riluzole is an established medication used in the management of ALS and may help modestly slow disease progression in some patients. Patients should not discontinue or modify Riluzole or other prescribed medicines when considering Ayurvedic care. Herbal and mineral-based formulations may interact with medications or affect liver and other organ functions. Any combination must be reviewed by the treating neurologist and qualified Ayurvedic physician.
Does early Ayurvedic consultation help in MND?
Early medical diagnosis and appropriate multidisciplinary management are important in MND. Early consultation at CHARAKA allows our physicians to understand the patient's condition, review available investigation reports and assess whether complementary Ayurvedic supportive care is appropriate. However, there is no established evidence that early Ayurvedic treatment changes the underlying progression of MND.
Can MND patients undergo treatment at CHARAKA?
Patients diagnosed with MND or ALS can consult the experienced Ayurvedic physicians at CHARAKA, Hyderabad, for an individualized assessment and discussion of complementary supportive care. The suitability of therapies depends on the patient's neurological condition, mobility, swallowing ability, respiratory status and existing treatment. Coordination with the treating neurologist is essential.
Can Motor Neurone Disease affect speech and swallowing?
Yes. MND can affect the muscles responsible for speech, chewing and swallowing, resulting in slurred speech (dysarthria), difficulty swallowing (dysphagia) and increased risk of choking or aspiration. Early assessment by speech and swallowing specialists is important to support safe nutrition and communication.
Can patients with advanced MND receive Ayurvedic treatment?
The suitability of Ayurvedic interventions in advanced MND depends on the patient's overall medical condition. Individuals with severe muscle weakness, swallowing difficulties or respiratory impairment require specialized medical and supportive care. Any complementary intervention must be carefully evaluated, and procedures involving significant physical stress should be avoided when unsafe.
How can family members support someone with Motor Neurone Disease?
Family members play an important role in supporting individuals with MND. Assistance with mobility, appropriate nutrition, communication, emotional well-being and regular medical follow-ups can make a meaningful difference. Respiratory assessment, swallowing evaluation, physiotherapy, occupational therapy and palliative care should be incorporated according to individual needs.